Literature DB >> 19224531

Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors.

Mohamed Ouardouz1, Elaine Coderre, Gerald W Zamponi, Shameed Hameed, Xinghua Yin, Bruce D Trapp, Peter K Stys.   

Abstract

OBJECTIVE: Glutamate receptors, which play a major role in the physiology and pathology of central nervous system gray matter, are also involved in the pathophysiology of white matter. However, the cellular and molecular mechanisms responsible for excitotoxic damage to white matter elements are not fully understood. We explored the roles of AMPA and GluR5 kainate receptors in axonal Ca(2+) deregulation.
METHODS: Dorsal column axons were loaded with a Ca(2+) indicator and imaged in vitro using confocal microscopy.
RESULTS: Both AMPA and a GluR5 kainate receptor agonist increased intraaxonal Ca(2+) in myelinated rat dorsal column fibers. These responses were inhibited by selective antagonists of these receptors. The GluR5-mediated Ca(2+) increase was mediated by both canonical (ie, ionotropic) and noncanonical (metabotropic) signaling, dependent on a pertussis toxin-sensitive G protein/phospholipase C-dependent pathway, promoting Ca(2+) release from inositol triphosphate-dependent stores. In addition, the GluR5 response was reduced by intraaxonal NO scavengers. In contrast, GluR4 AMPA receptors operated via Ca(2+)-induced Ca(2+) release, dependent on ryanodine receptors, and unaffected by NO scavengers. Neither pathway depended on L-type Ca(2+) channels, in contrast with GluR6 kainate receptor action.1 Immunohistochemistry confirmed the presence of GluR4 and GluR5 clustered at the surface of myelinated axons; GluR5 coimmunoprecipitated with nNOS and often colocalized with neuronal nitric oxide synthase clusters on the internodal axon.
INTERPRETATION: Central myelinated axons express functional AMPA and GluR5 kainate receptors, and can directly respond to glutamate receptor agonists. These glutamate receptor-dependent signaling pathways promote an increase in intraaxonal Ca(2+) levels potentially contributing to axonal degeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224531      PMCID: PMC3014988          DOI: 10.1002/ana.21539

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

Review 1.  Sodium-calcium exchange: a molecular perspective.

Authors:  K D Philipson; D A Nicoll
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

Review 2.  Glutamate receptors in glia: new cells, new inputs and new functions.

Authors:  V Gallo; C A Ghiani
Journal:  Trends Pharmacol Sci       Date:  2000-07       Impact factor: 14.819

3.  Noncanonical signaling by ionotropic kainate receptors.

Authors:  José Luis Rozas; Ana V Paternain; Juan Lerma
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

4.  Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter.

Authors:  S B Tekkök; M P Goldberg
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

Review 5.  The link between excitotoxic oligodendroglial death and demyelinating diseases.

Authors:  C Matute; E Alberdi; M Domercq; F Pérez-Cerdá; A Pérez-Samartín; M V Sánchez-Gómez
Journal:  Trends Neurosci       Date:  2001-04       Impact factor: 13.837

Review 6.  Cardiac calcium signalling.

Authors:  M J Berridge
Journal:  Biochem Soc Trans       Date:  2003-10       Impact factor: 5.407

7.  Changes in glial cell white matter AMPA receptor expression after spinal cord injury and relationship to apoptotic cell death.

Authors:  E Park; Y Liu; M G Fehlings
Journal:  Exp Neurol       Date:  2003-07       Impact factor: 5.330

8.  Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502.

Authors:  Eileen McCracken; Jill H Fowler; Deborah Dewar; Steve Morrison; James McCulloch
Journal:  J Cereb Blood Flow Metab       Date:  2002-09       Impact factor: 6.200

9.  Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors.

Authors:  Mohamed Ouardouz; Maria A Nikolaeva; Elaine Coderre; Gerald W Zamponi; John E McRory; Bruce D Trapp; Xinghua Yin; Weili Wang; John Woulfe; Peter K Stys
Journal:  Neuron       Date:  2003-09-25       Impact factor: 17.173

10.  Myoglobin: A scavenger of bioactive NO.

Authors:  U Flögel; M W Merx; A Godecke; U K Decking; J Schrader
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  37 in total

Review 1.  The back and forth of axonal injury and repair after stroke.

Authors:  Jason D Hinman
Journal:  Curr Opin Neurol       Date:  2014-12       Impact factor: 5.710

Review 2.  Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Prog Neurobiol       Date:  2010-10-12       Impact factor: 11.685

Review 3.  Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation.

Authors:  David P Stirling; Peter K Stys
Journal:  Trends Mol Med       Date:  2010-03-06       Impact factor: 11.951

4.  Ion channels boost axonal injury in multiple sclerosis.

Authors:  Reinhard Hohlfeld
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

Review 5.  Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.

Authors:  Monica Moreno; Fuzheng Guo; Emily Mills Ko; Peter Bannerman; Athena Soulika; David Pleasure
Journal:  J Neurol Sci       Date:  2013-01-05       Impact factor: 3.181

Review 6.  Ionic regulation of cell volume changes and cell death after ischemic stroke.

Authors:  Mingke Song; Shan Ping Yu
Journal:  Transl Stroke Res       Date:  2013-12-07       Impact factor: 6.829

7.  Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.

Authors:  Christel Steen; Nadine Wilczak; Johannes M Hoogduin; Marcus Koch; Jacques De Keyser
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

Review 8.  New approaches in the management of multiple sclerosis.

Authors:  Laurie J Barten; Douglas R Allington; Kendra A Procacci; Michael P Rivey
Journal:  Drug Des Devel Ther       Date:  2010-11-24       Impact factor: 4.162

9.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

10.  HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage.

Authors:  Jin Young Kim; Siming Shen; Karen Dietz; Ye He; Owain Howell; Richard Reynolds; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2009-12-27       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.